![Teva Buys World's Third Largest Generic Drugmaker in Biggest Israeli Acquisition to Date | The Tower Teva Buys World's Third Largest Generic Drugmaker in Biggest Israeli Acquisition to Date | The Tower](http://www.thetower.org/wp-content/uploads/2015/07/FeaturedImage_2015-07-27_171208_Flash90_Teva_F100323NS50.jpg)
Teva Buys World's Third Largest Generic Drugmaker in Biggest Israeli Acquisition to Date | The Tower
Tear Sheet: Teva Pharmaceuticals Faces Pressure From Competing Generics, Seeks to Delever Quickly After Actavis Acquisition - Reorg
![Teva Reaches Agreement With West Virginia to Settle the State's Opioid-Related Claims | Business Wire Teva Reaches Agreement With West Virginia to Settle the State's Opioid-Related Claims | Business Wire](https://mms.businesswire.com/media/20220523006055/en/739014/23/teva_RGB_JPEG.jpg)
Teva Reaches Agreement With West Virginia to Settle the State's Opioid-Related Claims | Business Wire
![Intas buys Teva's UK & Ireland assets for $764 million to break into global top 20 generic players club - The Economic Times Intas buys Teva's UK & Ireland assets for $764 million to break into global top 20 generic players club - The Economic Times](https://m.economictimes.com/thumb/msid-54696609,width-1200,height-900,resizemode-4,imgsize-173278/intas-buys-tevas-uk-ireland-assets-for-764-million-to-break-into-global-top-20-generic-players-club.jpg)
Intas buys Teva's UK & Ireland assets for $764 million to break into global top 20 generic players club - The Economic Times
![Teva and Ignyta Announce Acquisition by Ignyta of Four Oncology R&D Assets from Teva | Business Wire Teva and Ignyta Announce Acquisition by Ignyta of Four Oncology R&D Assets from Teva | Business Wire](https://mms.businesswire.com/media/20150317006367/en/457958/4/teva_logo.jpg)